Hvis topotecan anvendes under graviditet, eller hvis graviditet indtræder under behandlingen med topotecan, skal patienten advares om den potentielle risiko for barnet.
If topotecan is used during pregnancy, or if the patient becomes pregnant during therapy with topotecan, the patient must be warned of the potential hazards to the foetus.